Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Sets price band at ?695 to ?735 per Equity Share
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Subscribe To Our Newsletter & Stay Updated